At a Glance
| Diphenhydramine | Myristicin | |
|---|---|---|
| Class | Deliriant | Deliriant |
| Common Dose (oral) | 200–400 mg | 200–500 mg |
| Total Duration | 2.3–7 hrs | 13–24 hrs |
| Routes | oral | oral |
Dangerous Combination
Combining Diphenhydramine and Myristicin is classified as dangerous. Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure
Diphenhydramine, a Deliriant, and Myristicin, a Deliriant, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Deliriants, meaning they share a common pharmacological foundation. They share 48 documented effects in common, with 41 effects unique to Diphenhydramine and 22 unique to Myristicin. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Diphenhydramine | Myristicin | |
|---|---|---|
| Class | Deliriant | Deliriant |
| Common Dose (oral) | 200–400 mg | 200–500 mg |
| Total Duration | 2.3–7 hrs | 13–24 hrs |
| Routes | oral | oral |
| Effects |
| 89 documented |
| 70 documented |
| Interaction | Dangerous | |
| Level | Diphenhydramine | Myristicin |
|---|---|---|
| Threshold | 25 mg | 30 mg |
| Light | 100–200 mg | 50–200 mg |
| Common | 200–400 mg | 200–500 mg |
| Strong | 400–700 mg | 500–800 mg |
| Heavy | 700 mg | 800 mg |
Diphenhydramine
Myristicin
Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure